Drugs.com - Pharma Industry News

Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists

WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1...

Apr 30, 2025 - 18:55
 0
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1...
Read More

Tags:

Previous Article

Lorundrostat Beneficial for BP Reduction in Uncontrolled Hypertension

Next Article

Statin Use Improves Outcomes in Chronic, Small Lymphocytic Leukemia

Related Posts

Patients Mainly Prefer AI as Second Reader for Screening Mammogram

Patients Mainly Prefer AI as Second Reader for Screenin...

Apr 24, 2025  0

Prevalence of Most Cancer Risk Factors Unchanged Before, After Pandemic

Prevalence of Most Cancer Risk Factors Unchanged Before...

Apr 24, 2025  0

Moderately Preterm Birth Tied to Long-Term Cognitive Problems

Moderately Preterm Birth Tied to Long-Term Cognitive Pr...

Apr 25, 2025  0